Key Words human genome, manual annotation, ab initio prediction s Abstract Fifty years after the publication of DNA structure, the whole human genome sequence will be officially finished. This achievement marks the beginning of the task to catalogue every human gene and identify each of their function expression patterns. Currently, researchers estimate that there are about 30,000 human genes and approximately 70% of these can be automatically predicted using a combination of ab initio and similarity-based programs. However, to experimentally investigate every gene's function, the research community requires a high-quality annotation of alternative splicing, pseudogenes, and promoter regions that can only be provided by manual intervention. Manual curation of the human genome will be a long-term project as experimental data are continually produced to confirm or refine the predictions, and new features such as noncoding RNAs and enhancers have not been fully identified. Such a highly curated human gene-set made publicly available will be a great asset for the experimental community and for future comparative genome projects.
INTRODUCTION
Hailed as one of the most significant scientific achievements of the twenty-first century, sequencing the human genome has enabled a rapid expansion of the field of "omics" to help reveal the function of every human gene. However, nearly two years after both public and private efforts published their draft version of human genomic sequence (43, 85) , how much closer are we to understanding the nature of every human gene? Initial interpretation of the genomic sequence relied on conclusions derived mostly from bioinformatics approaches using ab initio predictions, homology studies, and motif analysis to predict gene function. Cataloguing genes and their regulatory sequences is just the start of a genome-wide approach to discover how the different components interact and contribute to biological processes and physiological complexity. Manual annotators will play a critical role in this development, interacting between biologists and the informatics community to determine the most reliable methods of producing a definitive view of the curated human genome. This review describes the current methods of gene prediction, manual assessment, comparative analysis, and experimental verification contributing to the production of a human gene-set. 1527 -8204/03/0728-0069$14.00
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ASHURST COLLINS
AUTOMATED VERSUS MANUAL ANNOTATION
Driven by the explosion in genomic data and a need to analyze draft data quickly, new methods of automated gene annotation have been developed over the past decade. Gene-finding in human genomic sequence is difficult due to the small amount of DNA that actually falls into coding regions (less than 5%) and the complexity of alternative splicing. Two important aspects of a gene-finding program are the type of information it uses and the algorithm. There are three types of information used by the program: signals in the sequence such as splice sites, content statistics such as codon usage, and similarity to known genes/proteins in the databases. Several sophisticated algorithms that deduce the presence of a gene feature using signals and content information have been devised (usually obtained by training with an experimental dataset) and are termed ab initio prediction programs. Rogic et al. (69) evaluated seven ab initio programs including GENSCAN (11) , Fgenes (76) , Genie (67) , and MZEF (99) , using an experimentally validated dataset of mammalian genomic sequences. They found a considerable proportion of missing or incorrect exons and overpredictions. In addition, they were able to detect only coding exons [5 and 3 untranslated regions (UTR)], and polyA sites were not predicted. Additional evidence is needed to confirm or improve these predictions.
Programs such as Genewise (8) and GenomeScan (96) combine protein sequence similarity with ab initio gene-finding algorithms to improve predictions. To examine the accuracy of various ab initio and similarity-based prediction programs on eukaryotic genomes, the Berkley Drosophila Genome Project organized an experiment called the Genome Annotation Assessment Project (GASP). Twelve groups used state of the art prediction tools to annotate the fully characterized Adh region from Drosophila (66) . Despite great progress, the experiment highlighted errors with the various predictions and indicated that both types of gene prediction programs are currently unable to determine whole gene structures consistently.
To publish the first view of the human draft sequence, two systems were developed using automated rules-based gene prediction systems attempting to mimic a human annotation system and quickly produce a good quality annotation of the draft sequence. Celera (85) designed the Otto package, which uses wellcharacterized datasets such as RefSeq (65) , SWISSPROT (4), and Human UniGene EST clusters (90) aligned to the draft sequence and then uses GENSCAN to detect and refine gene structures. In contrast, the Human Sequencing Consortium used the annotation generated by Ensembl database project (43) . Ensembl uses a three-step process incorporating a wide range of methods to produce a genomewide gene build. Initially, all human proteins from SPTREMBL are aligned with pmatch and turned into gene structures using Genewise (42) , and full-length cDNAs are aligned to provide UTR to these coding gene structures. This is repeated with nonhuman proteins to obtain novel proteins. Finally, GENSCAN is run across the entire genome, but only exons confirmed by proteins, vertebrate mRNAs, or UniGene clusters are assembled into genes. Gaasterland & Oprea (33) compared DNA transcripts for 26,544 Celera proteins and 29,304 Ensembl proteins and found that 7000 (26%) of the Celera-annotated genes had no BLASTN 71 sequence similarity with the Ensembl set. Since that comparison, the Ensembl gene count has decreased as gene fragments have merged and the annotation has improved, producing a current figure of 22,980 Ensembl gene predictions in the latest release (9.30a.1). Automated genome annotation systems are continually improving and have provided a necessary service in producing a first-pass annotation of draft genome sequence. However, attention is now turning to obtain a "gold standard" gene-set for the finished human genome sequence to be released in 2003, and realistically this will only be achieved by the intervention of manual curation.
Currently, the National Centre for Biotechnology Information (NCBI) reference sequences (RefSeq) provide a highly curated resource of human transcripts. To date there are 16,443 annotated transcripts assigned to 12,532 loci. They are transcript orientated and usually rely on full-length cDNAs for reliable curation, although the dataset also contains predictions using expressed sequence tags (ESTs), partial cDNAs, and proteins aligned against genomic sequence. The public sequencing centers participating in producing finished human genome are also involved in manual curation of their individual chromosomes. This is a mammoth task involving more than 12 centers worldwide. To date, four chromosomes have been manually annotated and published (21, 24, 39, 40) . Because consistent annotation across the whole human genome requires communication and interaction between different annotation groups, the Human Annotation Workshop (HAWK) was established in 2002 to create a forum where these groups could discuss manual annotation (http://www.sanger.ac.uk /HGP/havana/hawk.shtml). Draft annotation guidelines were produced to help new annotation groups annotate in a similar manner and at the high standard as other HAWK members, and are freely available on the website.
Several specialist annotation tools were designed by different groups to help with the manual annotation process. These include Apollo, currently used by Flybase; the Calhoun annotation system (J.E. Galagan, personnel communication); used for annotating Methanosarcina acetivorans; and Acedb (27, 48) , currently used as the front end for the Sanger Institute annotation system for vertebrate clones. Richard Durbin and Jean-Thierry Mieg originally created Acedb to manage data from the Caenorhabditis elegans sequencing project. It is continuously being developed and is used in the human annotation because of its graphical user interface Xace, which displays clone sequence and associated features in a graphical display called the Fmap. Figure 1 shows the typical view of the Fmap containing ab initio predictions, Ensembl gene structures, homology features, and the alternative-spliced gene structures that the manual curators produce. The aim is to produce a high-quality annotation that uses the latest gene-finding predictions, experimental sequence data, and software tools to produce consistent gene features across the genome.
GENE FEATURES ON THE HUMAN GENOME
Even before the release of the complete draft human genome sequence in 2001, different groups had tried to estimate the complete gene number using various methods (18, 28, 54) . The predictions ranged from 35,000 genes to 120,000 genes, and such a high variation was possibly attributed to problems with the definition and recognition of a gene as well as the methodology in finding genes. Defining a gene has become a difficult issue recently because everyone has a different understanding of the term. According to classical genetics, genes are inheritable units responsible for an associated phenotype. Although in some cases this relationship derives from mutation of noncoding DNA or regulatory elements, in most cases it is synonymous with protein-coding genes. It is incorrect to assume that any transcript represents a gene because some evidence of associated function should be established.
As different research groups are performing high-quality manual annotation of different chromosomes, it has been essential to standardize a set of definitions to describe the annotation of different gene features. The following are the gene indices used in Chromosome 20 annotation (21): (a) known genes, which are identical to human complementary DNA (cDNA) or protein sequences identified by LocusLink ID in LocusLink database (http://www.ncbi.nlm.nih.gov/LocusLink/); (b) novel genes, which have a open reading frame (ORF)/coding sequence (CDS) and are identical or homologous to known cDNAs (vertebrates) and/or proteins (all species); (c) novel transcripts, which are similar to novel genes except that no ORF can be unambiguously assigned; (d) putative genes, which are homologous to spliced ESTs (vertebrates) but devoid of significant ORF/CDS; and (e) pseudogenes, which are sequences homologous to proteins (in at least 50% of the subject length) with a disrupted CDS and for which an active gene can generally be found at another locus.
These definitions have also been used in the recent annotation of Chromosome 14 with an additional classification called "predicted genes." Genoscope used this new classification to describe a gene based on ab initio predictions for which at least one exon is covered by biological or similarity data (unspliced ESTs, mouse or tetraodon genomes, or expression data from Rosetta) (40) . The putative and predicted genes provide targets for experimental validation. Figure 2 shows a diagram of a generic gene including the various signals for splicing, polyadenylation, and transcriptional start sites. The following is a brief overview of the most common features predicted by manual annotation on the human genome, describing the identification of alternative splicing, polyA sites, pseudogenes, promoters, and noncoding RNAs.
Alternative Splicing
For more than 50 years, one mystery of genome evolution has been the C-value paradox. This refers to arbitrary and often large differences in genome size between eukaryotic organisms (38) . For example, the genomic size of the Drosophila melanogaster is 180 megabases (MB), whereas the European brown grasshopper (Podisma pedestra), with an evolutionary complexity similar to that of Drosophila, is 100 times larger at 18,000 MB. Therefore, the total amount of DNA in a genome has little correlation with the complexity and number of genes within the organism. A similar phenomena, which Claverie (13) termed the N-value paradox, is seen as more eukaryotic genomes are sequenced and annotated. Currently, the human genome is predicted to only contain twice as many gene loci as the C. elegans genome. One suggested mechanism, which may provide the required degree of complexity to differentiate worm from man, is alternative splicing.
Alternative splicing of pre-mRNA provides a versatile mechanism by which major developmental functions can be controlled and transcripts can be expressed in a cell-specific manner (55) . Analysis of alternative transcripts from the annotation of finished chromosomes reports 59% of gene loci display alternative splicing for Chromosome 22 (24) , 35% for Chromosome 20 (21) , and 54% for Chromosome 14 (40) , with an average 2.5 alternative transcripts per locus. The most extreme case of alternative splicing is in the Drosophila Dscam (Down Syndrome cell adhesion molecule) gene, which is reported to potentially generate >38,000 distinct mRNA transcripts (73) . In humans, this gene is located on Chromosome 21q22 and is thought to involve neural differentation and contribute to the central and peripheral nervous system defects in Down Syndrome (95) . Recent estimates of alternative splicing in the human genome suggest that up to 50% of genes could be alternatively spliced (43, 85) . This is (on average) a similar figure to what has been found for the individual annotated chromosomes so far. However, after examining seven different eukaryotic organisms with sufficient EST and mRNA coverage, Brett et al. (10) found that alternative splicing can be detected in a large number of organisms, including invertebrates. This suggests that EST coverage, rather than complexity of organism, is probably a major influencing factor to whether alternative splicing is detected. When analyzing exon skipping events in Chromosome 22, it was observed that high-EST coverage influences the number of human alternative transcripts identified (41) . There are currently more than 4.8 million human ESTs and 3.5 million mouse ESTs in release 122202 of database of ESTs (dbEST) (http://www.ncbi.nlm.nih.gov/dbEST/dbEST summary. html). Concerns have been raised about the reliability of some of these data leading to incorrect predictions using automated gene-finding (61) . For example, the dataset contains some oligo(dT)-primed genomic contamination and incompletely spliced heteronuclear RNA (hnRNA). However, describing the immature hnRNA as functionless may be premature because an alternative splice form that causes early translational termination of a protein could act as an important translation regulator (75) . Large-scale examination of 16,162 mRNAs, annotated in Locuslink (65), identified 1106 loci that generate 1989 distinct alternative transcripts that are targets for nonsense mediated decay (NMD) (53) . Therefore, the contribution of alternative splicing to proteome diversity may be balanced by a yet unappreciated regulatory role in gene expression.
One contribution of manual annotation to genome analysis is the careful annotation of alternative variants. The criterion chosen by the HAWK for annotating alternative transcripts is that EST/cDNA evidence used for gene prediction should splice. It is not essential that the variant has a CDS, therefore transcripts possibly involved in NMD would be annotated even if they do not code for a protein. ESTs from different species are also used as evidence to predict different transcripts on the premise that they may supply a wealth of information from different developmental stages not available for human cDNA libraries. Genome comparison studies between mouse and human have generally observed that gene structures are conserved and there is no reason to think this is not maintained between spliced variants (5, 45).
PolyA Sites and Signals
As well as contributing to the wealth of alternative transcript data, ESTs are essential for predicting poly(A) sites and signals. Alternative polyadenylation affects a large fraction of higher eukayotes, occurs in a tissue-dependent manner, and has been implicated in disease (26) . Determining the 3 end of a gene is straightforward because cDNAs are usually synthesised using oligo-d(T) primer to anchor them to their native mRNA. Comparison of 8775 human 3 UTRs from UTRdb (64) against 157,775 ESTs identified ten different polyadenylation signals, 58.2% represented by the signal AAUAAA and 14.9% by AUUAAA (6). In addition, Beaudoing et al. (6) found that the location of the signal peaked at a position 15-17 bases upstream of the putative poly(A) site. The signal AAUAAA is generally processed more efficiently than the others and is more frequent at most terminal 3 ends. This indicates that the major form of the alternatively polyadenylated mRNAs will generally be the longest. It also suggests that the longer form has a better stability than the shorter form.
Finding alternative poly(A) sites has not yet been incorporated into genomewide prediction programs because of the difficulty in interpreting evidence from EST clustering coupled with the abundance of different poly(A) signals within 3 exons. However, prediction programs such as POLYADQ exist which can predict both AAUAAA-and AUUAAA-dependent poly(A) sites in the human genome (82) . Currently, the most reliable method of polyadenylation site prediction is manual annotation. The 3 end of a gene is considered established if there is a run of at least four A residues not present in the genomic sequence, at the end of aligned cDNA, or EST sequence. In most cases, a poly(A) signal is detected within 60 bases of a poly(A) site.
Pseudogenes
The term pseudogene originally arose from investigation of the genome of Xenopus laevis (44) and is defined as a nonfunctional copy of a gene. Pseudogenes have evolved through two different mechanisms, either by retrotransposition or via duplication of genomic DNA. Pseudogenes arising from retrotransposition are known as processed pseudogenes and are generated by insertion into the genome as a double-stranded sequence generated from single-stranded mRNA (84) . All have similar characteristics such as an absence of 5 promoter sequence, introns, and a possible presence of a poly(A) tract at the 3 end. In contrast, pseudogenes arising from gene duplication, termed nonprocessed, often have a structure similar to their ancestral gene. Duplication of DNA segments is essential for developing complex genomes, yet the exact mechanism in which this occurs is still under debate (17, 34) . Almost all pseudogenes of both types contain frameshifts or/and stop codons in the coding region, presumably rendering them nonfunctional.
Pseudogene analysis is valuable for three reasons: first, because of pseudogenes' involvement in disease identification. For example, ribosomal proteins (RP) are implicated in human genetic diseases such as Noonan Syndrome (49) . Therefore, characterizing all pseudogenes in the genome will help researchers design specific primers for the functional RP genes. Second, pseudogenes can be used to study evolution and phylogenetic relationships between different organisms. Finally, processed pseudogenes can be used to study retrotransposition, as they can be considered similar to Alus (just like a special type of repetitive element). However, pseudogenes are more diverse than repetitive elements in terms of sequence length and high guanine and cytosine (GC) content. This makes them useful for studying evolution and dynamics of genomes.
Categorizing ORFs as functional genes or pseudogenes using the human draft sequence is difficult and has been avoided by automated genome-wide prediction programs. Most current pseudogene analysis in the human genome has been performed in a semimanual manner. Initially, when Harrison et al. (36) investigated the C. elegans finished sequence and corresponding annotation, they discovered one in eight genes was a pseudogene. Few of these pseudogenes appeared processed. They then turned to identifying and analyzing pseudogenes on the finished Chromosomes 21 and 22 (24, 39) . They used a method that searches for DNA regions similar to known proteins but with obvious frameshifts or in-frame stop codons while ensuring minimal overlap with annotated known genes. Putative processed pseudogenes were annotated if >70% of their length matched closely to a human protein and/or there was evidence of a poly(A) tract. They found 190 new pseudogenes beyond those reported by the sequencing centers and annotated 189 processed and 195 nonprocessed pseudogenes (37) . Analysis of the processed genes revealed that approximately 20% of pseudogenes corresponded to ribosomal protein sequences. Examination of the whole genome sequence revealed 2090 processed RP pseudogenes and their sequence divergence from present-day RP genes revealed an age distribution similar to that of Alu repetitive elements (101).
Transcriptional Start Sites and Promoter Predictions
Transcription initiation is the first step in gene expression, a major point of regulation, and a complex process (97) . Once chromatin around the promoter has been modified into a hyperacetylated and relaxed state associated with transcriptionally active chromatin, the preinitiation complex binds to the core promoter, which lies approximately 100 basepair (bp) either side of the transcriptional start site (TSS). Transcription initiation is controlled mainly by transcriptional factors that bind to the proximal region of the promoter, which lies approximately 1 kilobase (kb) upstream of the TSS, and to the first exon region. CpG islands are stretches of nonmethylated DNA rich in CG dinucleotides that are scattered throughout the genome, mostly occurring at the 5 end of genes and containing both promoter sequence and TSSs. Approximately 56% of mammalian genes, including all housekeeping genes, are associated with CpG islands (19) and thus can aid TSS identification. Other methods of identifying TSSs and promoter regions linked to different genes require aligning full-length transcripts against the genome sequence.
Most cDNAs submitted to the nucleotide databases are incomplete because conventional methods for determining TSSs, such as 5 rapid amplification of cDNA ends (RACE) (32, 71) or primer extension (59) , are laborious and not really suited for high-throughput protocols. Recently, however, the oligo-capping method (57, 80) was developed, which replaces the cap structure of a full-length mRNA with a synthetic oligonucleotide. This results in the production of an mRNA with sequence tags [3 poly(A) and 5 cap-replaced oligo] at both ends to aid selection. The resulting cDNA libraries are significantly enriched for full-length cDNAs. Using this technology, Suzuki et al. (79) produced a resource database, Database of Transcriptional Start Sites (DBTSSs), containing 111,382 full-length sequences that match 7889 cDNA sequences of known genes. Comparing their entries to the RefSeq sequences revealed that 34% of RefSeqs are missing their 5 end. This suggests that the DBTSS database will be a vital resource for analyzing TSSs and promoter studies using full-length mRNAs.
Currently, many promoter and TSS prediction programs are available. However, their performance has been unreliable with respect to false-positive predictions (29, 62, 89, 100) . Recently, two programs were developed that produce more reliable predictions for genome-wide promoter scans: PromoterInspector (72) and Eponine (23) . PromoterInspector analyzed the complete published sequence of Chromosome 22 (24) for promoters and found that about 40% of 465 predicted regions are supported by available gene annotation. Eponine performs with similar sensitivity (a measure to detect true positives) and specificity (a measure of the ability to discriminate against false negatives) as PromoterInspector, but it can more precisely predict the TSSs because it only models features that represent the TATA and CpG components of the promoter immediately adjacent to the TSS. A third method was developed that utilized the full-length cDNA data produced by Suzuki et al. (79) to construct a first-exon database by mapping 2130 transcripts to genomic sequence. Analyzing this database revealed that 39% of first exons were noncoding and on average shorter than partially coding first exons (151 bp compared to 348 bp). Davuluri et al. (20) also studied the relationship between CpG islands and first exons, and found that 70% of first exons in their database were CpG-related. Based on their analysis of the database they produced a program, named FirstEF, for predicting first exons in genomic sequence. This program combines models of the first exon, first exon splice donor sites, and the promoter region upstream of TSSs. Analyzing both Chromosome 22 and 21 (24, 39) finished sequence identifies 74% and 67%, respectively, of first exons from their annotation (20) . These results indicate that FirstEF is probably the most effective promoter-finding program to date.
Noncoding RNAs
Approximately 98% of all transcriptional output in humans is noncoding RNA (ncRNA) (58) . When predicting gene numbers, this class of gene has been consistently overlooked because focus is placed on protein-coding genes (94) . The reasons for this are the limitations of the current three methods used for gene estimation: cDNA and EST sequencing of mRNAs (28, 54) , computational prediction (43, 85) , and comparative genome analysis identifying conserved ORFs (18) . These methods essentially do not work for ncRNA genes, which produce transcripts that function as structural, catalytic, or regulatory RNAs rather than mRNAs that encode a protein. Although many genomes have been sequenced and annotated, both the number and diversity of ncRNA genes remain unknown quantities.
ncRNAs come in various forms (25, 78, 81) and therefore it is hard to imagine that one gene-finding approach will be successful for all types. Noncoding RNAs include transfer RNA (tRNA), ribosomal RNAs (rRNA), small nucleolar RNAs, and small nuclear RNAs, and the nomenclature of these RNAs is sometimes confusing with redundant terminology. One class of ncRNAs that appears to have a large impact on the function of an organism is antisense RNAs. They are involved in gene silencing using a variety of methods. The X (inactive) specific transcript (XIST) gene product, a 17-kb antisense ncRNA, is involved in silencing X-linked genes by modifying chromatin by either methylation of promoters or deacetylation of histones (9, 14) . Other antisense RNA examples have been found within imprinted clusters and include the imprinted Prader-Willi syndrome (IPW) and imprinted maternally expressed untranslated mRNA (H19) transcripts (70) . Detailed reannotation of the finished Chromosome 22 has revealed 16 potential cis-antisense RNAs (i.e., RNAs that overlap coding genes on the opposite genomic strand) (15) . As more cis-antisense RNAs are found covering various loci within the genome, it is unlikely that their role is limited to imprinting and chromatin structure.
As both experimental and computational biologists devise new strategies to specifically detect eukaryotic ncRNAs, annotating these structures will greatly improve. The Rfam database (1.0) containing 25 families, comprising over 50,000 noncoding RNA genes contained within the European Molecular Biology Laboratory (EMBL) nucleotide database, has already been released (35) . In addition, the wealth of genomic sequence from a variety of organisms enables use of comparative analysis techniques. This has proved successful when comparing Escherichia coli intergenic regions with five other enterobacterial genomes where the QRNA program identified 275 potential ncRNAs (68) . Subsequent experimental verification confirmed that some predictions were functional ncRNAs (86) . The growing importance of ncRNAs shows that to fully understand regulatory genetics we must look beyond the proteome when analyzing the genome.
COMPARATIVE ANALYSIS
Homologous genes are derived from a common ancestral gene, and their level of sequence similarity indicates the rate of divergence from their common ancestor. There are two classifications of homologous genes: orthologues, which are derived from the same gene in the last common ancestral species and thus have similar functions, and paralogues, which are produced by duplicating a chromosomal segment and typically have different functions. It is well established that comparative analysis of genomic sequence from species at different evolutionary distances is a powerful method for identifying coding sequences and conserved noncoding sequences with regulatory functions, and for highlighting unique species-specific sequences (31, 60, 83, 87) . The recent completion of the mouse draft sequence is one of the latest key sources of information for unravelling the contents of the human genome (88) . From initial comparative analysis, approximately 80% of mouse genes have a single identifiable orthologue in the human genome and less than 1% of mouse genes lack a detectable homologue in the human genome. Using the knowledge obtained from both genomes, biomedical studies of human genes and experimental manipulation of the corresponding genes in mouse will lead to a deeper insight into their function.
Computational tools such as TWINSCAN (52), SGP-1 (syntenic gene prediction) (91) , and SLAM (2) were developed to compare genomic sequence from two species by pairwise similarity and combine it with ab initio prediction to improve gene-structure predictions. Using TWINSCAN, Flicek et al. (30) recently predicted a conservative 25,622 genes when using the mouse draft genome sequence, whereas Alexandersson et al. (2) were able to detect at exon level 79.8% of human RefSeq exons in the human gene-set using SLAM. Recently, groups involved in the manual annotation of human Chromosomes 20 and 14 and reanalysis of Chromosome 22 examined various comparative data to improve or confirm gene predictions. Deloukas et al. (21) found that a combination of mouse whole shotgun reads and evolutionary conserved regions (Ecores) derived from Tetraodon genomic sequences detected over 94% of known and novel gene exons on Chromosome 20. Heilig et al. (40) used a similar combination and found 11 predicted genes that were supported only by ab initio predictions and comparative data. As discussed in the Chromosome 22 reannotation paper, whereas the crossspecies analysis and prediction programs are useful for identifying and confirming expressed regions of the genome, the gene structures are usually constructed from cDNA-derived sequences data and exclude exons supported by cross-species genomic matches only (15) .
GENE ONTOLOGY AND COMMUNITY ANNOTATION
As more genomes are sequenced and annotated a need has arisen to unify description of gene products within the model organism databases. An ontology, defined in terms of structured vocabulary, is a hierarchy of terms in which these terms are precisely defined and relate to one another in a meaningful way. The Gene Ontology (GO) Consortium (3, 16) was formed to develop shared structured vocabularies for annotating molecular characteristics across various organisms. These characteristics are divided into the three categories and have precise definitions and relationships to one another. The organization of the terms is arranged as a directed acyclic graph allowing a term to appear in several hierarchies (see Figure 3 ). Vocabulary terms are linked by "is a" and "part of " relationships so that both general terms and precise terms are represented.
Many generic databases, including Ensembl, Interpro LocusLink, and SWISS-PROT, include GO terms in their annotation either manually or automatically. Assigning GO terms/accession numbers to a gene product allows rapid comparison and cross-reference between these databases. GO annotation has been a prominent feature in maintaining consistency in the recent functional annotation of mouse meeting (FANTOM) project community annotation of mouse cDNAs.
Community genome annotation began in 2000, coinciding with the release of the Drosophila Genome sequence. Termed the Drosophila Jamboree, 40 scientists collaborated over a two-week period to complete a preliminary annotation of the Drosophila genome (1). FANTOM was organized in 2001 to bring together experts in the fields of bioinformatics and biology to annotate 21,076 cDNAs sequenced at RIKEN as part of the Mouse Gene Encyclopaedia Project (47) . One or more GO terms were assigned to 3025 of the 9902 clones that had a definitive coding region (47) . All annotated cDNA sequences were submitted to DDBJ sequence database after publication, making it an important resource for the mammalian research community. FANTOM2 proceeded the following year and involved manual annotation of 60,770 full-length cDNAs clustered into 33,409 transcriptional units (TU). Analyzing these TUs indicated that approximately one third were noncoding messages, indicating that ncRNAs are a large component of the mouse transcriptome (63) . As the annotation of the transcriptome is completely supported by physical clones, it provides a valuable resource for the functional analysis of the mammalian transcriptome.
Attempting to mimic the success of the FANTOM's community annotation, the H-Invitational project was organized in 2002. This concentrated on annotating human cDNA clones already sequenced and submitted to the sequence databases as part of the different high-throughput cDNA projects such as mammalian gene collection (56) and the programs coordinated by Kazusa (51), DKFZ (92) , and Nedo (98) . Over 21,000 cDNAs were manually annotated in ten days and provide a resource twice the size of the reviewed RefSeq dataset currently available from NCBI. Hopefully the results of this annotation effort will be publicly available in early 2003. This type of jamboree style annotation project is a valuable method of attributing functionality to cDNAs quickly and consistently. It is debatable how sustainable this method of community annotation is. To provide the community with a reliable resource, a regularly reanalyzed and updated centralized repository of manually curated genome annotation is needed.
EXPERIMENTAL VERIFICATION: FROM ANALYSIS TO LABORATORY CONFIRMED GENES
Once a chromosome or genomic region has been annotated, experimental verification is needed to confirm the predictions and add extra data. The preliminary structures can be confirmed using cross exon polymerase chain reaction (PCR), partial genes extended by RACE (32), or vectorette PCR cDNA library screening (15) . Primers designed from exons of a preliminary structure can be used to amplify an appropriate cDNA source and the fragment sequenced to confirm or refute predictions. Adjacent annotated structures can be joined together by amplifying between exons to provide evidence for continuity between them at the transcript level. Primers designed in the most 5 exon can be used to extend the annotation further 5 until the gene is considered complete.
The computational analysis of genomic sequence and the directed cDNA sequencing described above create a lot of data for manual review. The annotator's job is to distinguish between the true transcribed sequence and noise. To assess the utility of genomic sequence analysis, the gene annotation of Chromosome 22 has been compared to a range of data sources, and the sensitivity and the specificity (12) have been calculated (15) . The results suggest that the large dbEST collection identifies most of the annotation and can be used to define the exon/intron structure of three quarters of the annotated bases, but at the expense of specificity, where more than half the nucleotides matched in the genomic sequence do not contribute to the annotation. Taking a set of curated vertebrate mRNA sequences representing more full-length transcripts, only two thirds of the exon/intron structures are identified, but the specificity nearly doubles. These data suggest that continued sequencing of full-length transcripts should greatly assist the annotation process.
Limited understanding of the complexities of human cell biology makes imposing a set of annotation rules difficult. Several problems are encountered during the annotation of human sequence. Errors in cDNA or genomic DNA sequence can prevent accurate gene annotation. This is particularly a problem when insertions or deletions cause a frameshift. Polymorphisms can cause a similar problem but are biologically significant and need to be annotated. To confirm a base alteration as a polymorphism or reject it as a sequencing error or clone artifact, genomic fragments from unrelated individuals are amplified by PCR, sequenced, and compared. Cloning artifacts were shown to be present in certain cDNA libraries and can be observed in EST sequences (15, 93) . Incomplete splicing and chimeric cDNA clones provide conflicting and confusing data for gene annotation. The true 3 end of a gene can be confirmed by checking the genomic sequence immediately 3 of the end of a gene. This sequence is occasionally a poly(A) tract indicating a further cDNA artifact. Gaps in genomic DNA result in incomplete annotation, whereas cDNA that extend into gaps are useful for isolating the gap-filling clones. Several annotations were observed containing exons that overlap repeat sequences. It remains to be seen whether these have any biological function. Partial gene duplications are often seen throughout genomic DNA. Part of a gene has been duplicated, but in contrast to conventional unprocessed pseuodogenes, the open reading frame has not been lost, yet there is no evidence of transcription (15) . Such genes are often annotated as incomplete genes that require further laboratory confirmation, but may represent additional pseudogenes. As genome projects progress, transcript and protein databases continue to grow. Generally, this is useful for annotation; however, if incorrect gene annotations are submitted to the public databases, they eventually return to the original sequence as evidence for a gene.
Shoemaker et al. (74) , using exon and tiling microarrays made by ink-jet oligonucleotide synthesis, devised an experimental approach to validate and refine the published gene predictions for Chromosome 22q. They identified 85% of the known genes from Dunham et al. (24) , but also found support for 57% of pure Genscan predictions (with no supporting evidence). Similary, Kapranov et al. (46) found more transcribed sequences than predicted for Chromosomes 22 and 21 when using oligonucleotide arrays containing probes spaced every 35 bp along these chromosomes. They suggest that these new sequences could be noncoding RNAs not identified previously. More data from this type of high-throughput experimental technology will reveal vital clues about the roles of expressed genes and will enhance the annotation.
VIEWING CURATED DATA
At the time of writing, there was not a single site available that distributes all the annotation associated with the published finished chromosomes. UCSC (50), Ensembl (42) , and NCBI (65) are the main sites where researchers access human genomic data, yet these sites concentrate on displaying a multitude of automated annotation and prediction data. Not even the sequence databases EMBL/NCBI/DDBJ contain all the current versions of annotation because submitting annotated sequence files is not mandatory prior to publication. Because it is becoming easier to construct a genome browser in-house with freely available software from the Generic Model Organism System Database Project (GMOD) (77) , institutes prefer to maintain and distribute their annotation from their own website. One advance that allows the researchers to visualize various annotations in a single place is the Distributed Annotation System (DAS) (22) . The system uses DAS Extensible Markup Language (XML) as the exchange format, and any client or server adhering to the format specification can participate in the system. This enables individuals to maintain and update annotation locally, yet allows individuals to view the results elsewhere in a different browser.
Due to launch in early 2003, the Vertebrate and Genome Analysis (VEGA) database, http://vega.sanger.ac.uk, will be a much needed browsable resource containing all the manual annotation produced by the public sequencing consortium as it is published. Based on the Ensembl schema (7), the VEGA browser will also display experimental evidence directly associated with each prediction and provide an important feedback mechanism by which the bench scientist can contact the annotators to correct or improve the annotation. Because the annotation is not a result of automatic gene build programs, localized amendments can be made to gene predictions quickly and therefore should be an accurate continually updated genomic resource for the research community.
FUTURE DIRECTION OF GENE ANNOTATION
Whole genome annotation is a continual process and we are still in the primary phase. The public sequencing consortium hopes to produce a high-quality manual annotation along with finished sequence of the human genome within the next year. Improved methods of comparative analysis and promoter predictions will enable regulatory regions to be annotated and aid experimental verification. The sequencing and annotation of different haplotypes over selected regions of the genome will help our understanding of genes involved in complex diseases such as diabetes and schizophrenia. Incorporating results from high-throughput experiments such as microarray expression analysis, yeast two-hybrid, long-range serial analysis of gene expression (SAGE), or green fluorescent protein tagging of proteins will add further functional information to enhance the gene annotation. How this type of information will be incorporated at the gene level has not been decided. Unlike Flybase, Wormbase, or the Mouse Genome Informatics database (MGI), there is currently no central repository that supplies all curated data associated specifically to the human genome. LocusLink at NCBI is the closest entity to a human curated database as it acts as an access point to various curated databases such as Online Mendelian Inheritance in Man (OMIM), Human Gene Nomenclature Database (HGDB), and various genome browsers. Over the next few years the aim will be to integrate all types of computational, curated, and experimental data in a single repository, enabling the biologist to look at a gene sequence and determine its biological role within the cell. 
